Anti-Human CD11c – DyLight® 650
Anti-Human CD11c – DyLight® 650
Product No.: C1687
- -
- -
Clone 3.9 Target CD11c Formats AvailableView All Product Type Monoclonal Antibody Alternate Names gp 150/95 Isotype IgG1 Applications FA , FC |
- -
- -
Antibody DetailsProduct DetailsReactive Species Human Host Species Mouse Immunogen Purified Recombinant Human CD11c (>98%) Product Concentration 0.2 mg/ml Formulation This DyLight® 650 conjugate is formulated in 0.01 M phosphate buffered saline (150 mM NaCl) PBS pH 7.4, 1% BSA and 0.09% sodium azide as a preservative. Storage and Handling This DyLight® 650 conjugate is stable when stored at 2-8°C. Do not freeze. Country of Origin USA Shipping Next Day 2-8°C Excitation Laser Red Laser (652 nm) RRIDAB_2828746 Applications and Recommended Usage? Quality Tested by Leinco FC The suggested concentration for this 3.9 antibody for staining cells in flow cytometry is ≤ 1.0 μg per 106 cells in a volume of 100 μl or 100μl of whole blood. Titration of the reagent is recommended for optimal performance for each application.> Additional Reported Applications For Relevant Conjugates ? IHC (Frozen) FA For specific conjugates of this clone, review literature for suggested application details. Each investigator should determine their own optimal working dilution for specific applications. See directions on lot specific datasheets, as information may periodically change. DescriptionDescriptionSpecificity Clone 3.9 recognizes the α-chain (CD11c) of the CD11c/CD18 complex. It is specific for the I domain of CD11c. Clone 3.9 binds the activated form of CD11c and partially blocks the binding of CD11c with ICAM-4. Background LFA-1α (CD11a) and CD18 are the Integrin alpha-L and beta-2 chains respectively that combine to form LFA-1, a glycoprotein and a member of the Integrin family. Integrin alpha-L/beta-2 is a receptor for ICAM1, ICAM2, ICAM3, ICAM4 and for F11R. LFA-1 participates in the immunological synapses between CD8+ T lymphocytes and antigen-presenting cells. The absence of LFA-1α or ß may induce LAD. The antigen contributes to natural killer cell cytotoxicity, and is involved in various immune phenomena such as leukocyte-endothelial cell interaction, cytotoxic T-cell mediated killing, and antibody dependent killing by granulocytes and monocytes. The CD11b/CD18 antigen is a heterodimeric surface glycoprotein on leukocytes and belongs to the ß2 integrin family. CD11b functions as a receptor for C3bi complement, clotting factor X, fibrinogen and ICAM-1. CD11c forms an α/ß heterodimeric glycoprotein (CD11c/CD18 complex) which belongs to the ß2 integrin family. The complex binds fibrinogen and reportedly serves as a receptor for iC3b and ICAM-1. During inflammatory responses, it mediates cell to cell interaction and is important in both monocyte adhesion and chemotaxis. Antigen Distribution CD11c is primarily expressed on dendritic cells, NK cells, a subset of intestinal intraepithelial lymphocytes (IEL), and some activated T cells. Ligand/Receptor CD54, fibrinogen, iC3b, ICAM-1, ICAM-4 PubMed NCBI Gene Bank ID UniProt.org Research Area Cell Adhesion . Cell Biology . Costimulatory Molecules . Immunology . Innate Immunity . Neuroscience . Neuroscience Cell Markers References & Citations1. Leukocyte Typing V (1995) Oxford University Press
2. Leukocyte Typing IV (1989) Oxford University Press
3. Leukocyte Typing III (1987) Oxford University Press
4. Hogg, N. et al. (1986) Eur. J. Immunol. 16:240
5. Malhotra, V. et al. (1986) Eur. J. Immunol. 16:1117 Technical ProtocolsFA  Certificate of Analysis |
Related Products
- -
- -
Prod No. | Description |
|---|---|
C2130 | |
C2131 | |
C2439 | |
C2124 | |
C2122 | |
C2120 | |
C2121 | |
C2087 | |
C2123 | |
C2125 | |
C2126 | |
C2127 | |
C2129 | |
C2119 |
Formats Available
- -
- -
Prod No. | Description |
|---|---|
C1691 | |
C145 | |
C146 | |
C147 | |
C148 | |
C1683 | |
C1684 | |
C1685 | |
C1687 | |
C1689 | |
C369 | |
C669 |
Products are for research use only. Not for use in diagnostic or therapeutic procedures.
